Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays

Maria Eugenia de la Morena-Barrio, Pierre Suchon, Eva Marie Jacobsen, Nina Iversen, Antonia Miñano, Belén de la Morena-Barrio, Carlos Bravo-Pérez, Jose Padilla, Rosa Cifuentes, Susana Asenjo, Jean François Deleuze, David Alexandre Trégouët, Maria Luisa Lozano, Vicente Vicente, Per Morten Sandset, Pierre Emmanuel Morange, Javier Corral

Blood (2022) 140 (2): 140–151.

https://doi.org/10.1182/blood.2021014708

Published: 2022

Includes: Supplemental data

Journal Articles

Molecular Characterization of Two Homozygous Factor VII Variants Associated with Intracranial Bleeding

Elisabeth Andersen, MSc, PhD, Maria Eugenia Chollet, MD PhD, Marit Sletten, Benedicte Stavik, PhD, Christiane Filion Myklebust, MSc, Ellen Skarpen, PhD, Paul Hoff Backe, Per Morten Sandset, MDPhD, Heidi Glosli, Carola Henriksson, Nina Iversen

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-139219

Published: 2020

Journal Articles

Tissue Factor Pathway Inhibitor Enhances Transendothelial Migration of Chronic Lymphocytic Leukemia Cells through Binding to Glypican-3

Xueyan Cui, MD PhD, Geir Erland Tjønnfjord, MD DMsc, Sandip Kanse, PhD, Nina Iversen, PhD, Anders EA Dahm, MD PhD, Christiane Filion Myklebust, Ling Sun, MD PhD, Zhong Xing Jiang, MD PhD, Mitchell Ho, PhD, Per Morten Sandset

Blood (2018) 132 (Supplement 1): 2452.

https://doi.org/10.1182/blood-2018-99-111241

Published: 2018

Journal Articles

Increased Bone Marrow Microvascular Density in Hematologic Malignancies

Helene Francisca Stigter Negaard, MD, Nina Iversen, PhD, Inger Marie Bowitz-Lothe, MD, Per Morten Sandset, MD, PhD, Brit Steinsvik, Bjørn Østenstad, MD, PhD, Per Ole Iversen, MD, PhD

Blood (2008) 112 (11): 5456.

https://doi.org/10.1182/blood.V112.11.5456.5456

Published: 2008

Journal Articles

Production of Tissue Factor Pathway Inhibitor in Endothelial Cell Cultures Is Reduced by Estrogens, Selective Estrogen Receptor Modifiers, and a Selective Estrogen Receptor Downregulator.

Anders E.A. Dahm, MD, Nina Iversen, PhD, Baard Birkenes, Per Morten Sandset, MD, PhD

Blood (2005) 106 (11): 3961.

https://doi.org/10.1182/blood.V106.11.3961.3961

Published: 2005

NARROW

Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays

Molecular Characterization of Two Homozygous Factor VII Variants Associated with Intracranial Bleeding

Tissue Factor Pathway Inhibitor Enhances Transendothelial Migration of Chronic Lymphocytic Leukemia Cells through Binding to Glypican-3

Increased Bone Marrow Microvascular Density in Hematologic Malignancies

Production of Tissue Factor Pathway Inhibitor in Endothelial Cell Cultures Is Reduced by Estrogens, Selective Estrogen Receptor Modifiers, and a Selective Estrogen Receptor Downregulator.

Email alerts

ASH Publications

American Society of Hematology

Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays

Molecular Characterization of Two Homozygous Factor VII Variants Associated with Intracranial Bleeding

Tissue Factor Pathway Inhibitor Enhances Transendothelial Migration of Chronic Lymphocytic Leukemia Cells through Binding to Glypican-3

Increased Bone Marrow Microvascular Density in Hematologic Malignancies

Production of Tissue Factor Pathway Inhibitor in Endothelial Cell Cultures Is Reduced by Estrogens, Selective Estrogen Receptor Modifiers, and a Selective Estrogen Receptor Downregulator.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only